Rescue of gene expression by modified REST decoy oligonucleotides in a cellular model of Huntington's disease

Article English OPEN
Soldati, Chiara ; Bithell, Angela ; Conforti, Paola ; Cattaneo, Elena ; Buckley, Noel J (2011)

Transcriptional dysfunction is a prominent hallmark of Huntington's disease (HD). Several transcription factors have been implicated in the aetiology of HD progression and one of the most prominent is repressor element 1 (RE1) silencing transcription factor (REST). REST is a global repressor of neuronal gene expression and in the presence of mutant Huntingtin increased nuclear REST levels lead to elevated RE1 occupancy and a concomitant increase in target gene repression, including brain-derived neurotrophic factor. It is of great interest to devise strategies to reverse transcriptional dysregulation caused by increased nuclear REST and determine the consequences in HD. Thus far, such strategies have involved RNAi or mutant REST constructs. Decoys are double-stranded oligodeoxynucleotides corresponding to the DNA-binding element of a transcription factor and act to sequester it, thereby abrogating its transcriptional activity. Here, we report the use of a novel decoy strategy to rescue REST target gene expression in a cellular model of HD. We show that delivery of the decoy in cells expressing mutant Huntingtin leads to its specific interaction with REST, a reduction in REST occupancy of RE1s and rescue of target gene expression, including Bdnf. These data point to an alternative strategy for rebalancing the transcriptional dysregulation in HD.
  • References (84)
    84 references, page 1 of 9

    Abrajano J. J., Qureshi I. A., Gokhan S., Zheng D., Bergman A. and Mehler M. F. (2009a) Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation. PLoS ONE 4, e7665.

    Abrajano J. J., Qureshi I. A., Gokhan S., Zheng D., Bergman A. and Mehler M. F. (2009b) REST and CoREST modulate neuronal subtype specification, maturation and maintenance. PLoS ONE 4, e7936.

    Aharoni-Simon M., Reifen R. and Tirosh O. (2006) ROS-productionmediated activation of AP-1 but not NFkappaB inhibits glutamateinduced HT4 neuronal cell death. Antioxid. Redox Signal. 8, 1339- 1349.

    Altar C. A., Cai N., Bliven T., Juhasz M., Conner J. M., Acheson A. L., Lindsay R. M. and Wiegand S. J. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860.

    Bae B. I., Xu H. and Igarashi S. et al. (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29-41.

    Ballas N., Battaglioli E. and Atouf F. et al. (2001) Regulation of neuronal traits by a novel transcriptional complex. Neuron 31, 353- 365.

    Bates G. P. (2005) History of genetic disease: the molecular genetics of Huntington disease - a history. Nat. Rev. Genet. 6, 766-773.

    Battaglioli E., Andres M. E., Rose D. W., Chenoweth J. G., Rosenfeld M. G., Anderson M. E. and Mandel G. (2002) REST repression of neuronal genes requires components of the hSWI.SNF complex. J. Biol. Chem. 277, 41038-41045.

    Bithell A., Johnson R. and Buckley N. J. (2009) Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease. Biochem. Soc. Trans. 37, 1270-1275.

    Brown D. A., Kang S. H., Gryaznov S. M., DeDionisio L., Heidenreich O., Sullivan S., Xu X. and Nerenberg M. I. (1994) Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801-26805.

  • Related Research Results (1)
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Central Archive at the University of Reading - IRUS-UK 0 27
Share - Bookmark